Oppenheimer analyst Jason Helfstein maintains Meta Platforms (NASDAQ:META) with a Outperform and raises the price target from $220 to $235.
Rutgers University And Quest Diagnostics Double H.O.P.E. Clinic Capacity With Expanded Collaboration
Rutgers University and Quest Diagnostics are expanding their collaboration to further improve access to critical primary care services for uninsured and underinsured patients of the university's Health Outreach
